Australia provides medical equipment worth Rs 4.1 million to TU Teaching Hospital My Republica
The equipment, July 7 Ambassador of Australia to Nepal Felicity Volk on Tuesday handed over medical equipment worth AUD 45,450 (approximately Rs 4.1 million ) to Professor Dr Dibya Singh Shah, Dean of the Institute of Medicine (IOM), Tribhuvan University Teaching Hospital (TUTH) and Dr Samarika Dahal at the Forensic Department of TUTH.
an ultrasound machine and a portable dental x-ray machine - were funded under the Australia Awards Alumni Grants Program to support the work of two Australian university alumni - Professor Dr Shah and Dr. Dahal.
According to the Embassy of Australia in Kathmandu, the x-ray machine will be used in forensic odontology services in Nepal and will expand the disaster victim identification services provided by the Forensic Department at TUTH. Dr Dahal is pioneer in the field of forensic odontology and received the alumni grant in recognition
Australia
Kathmandu
Bagmati
Nepal
Australian
Dibya-singh-shah
Samarika-dahal
Australia-awards-alumni-grants-program
Dean-of-the-institute-medicine
Australia-awards-women-in-leadership-network
Embassy-of-australia
Development-response-plan
Nepal PM Oli takes India-made Covishield vaccine
International
Updated: Sunday, March 7, 2021, 18:59 [IST]
Kathmandu, Mar 07: Nepal Prime Minister K P Sharma Oli took the India-made Covishield coronavirus vaccine on Sunday, as the Himalayan nation gears up to start the second phase of its immunisation drive.
The 69-year-old Nepalese leader received the Covishield jab at the Tribhuvan University Teaching Hospital here on Sunday morning. His wife Radhika Shakya was also vaccinated.
Nepal Prime Minister K P Sharma Oli
The Covishield vaccine was developed in a collaboration between Oxford University and pharmaceutical company AstraZeneca. It is manufactured by Pune-based Serum Institute of India.
Kathmandu
Bagmati
Nepal
India
Nepalese
Pradeep-kumar-gyawali
Radhika-shakya
Hridayesh-tripathi
Dibya-singh-shah
Bishnu-poudel
Johns-hopkins-university
Astrazeneca